Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Liver Metastases From Colorectal Cancer”

81 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 81 results

Testing effectiveness (Phase 2)UnknownNCT00997685
What this trial is testing

Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

Who this might be right for
Potentially Resectable Liver Metastasis From CRCColorectal Cancer
Guangdong Provincial People's Hospital 110
Testing effectiveness (Phase 2)Study completedNCT00003433
What this trial is testing

Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Duke Cancer Institute
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07441369
What this trial is testing

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Who this might be right for
Liver Metastases From Colorectal Cancer (mCRC)
Fudan University 16
Large-scale testing (Phase 3)UnknownNCT00002793
What this trial is testing

Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Johann Wolfgang Goethe University Hospital 336
Testing effectiveness (Phase 2)Looking for participantsNCT03401294
What this trial is testing

Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
University of Saskatchewan 32
Testing effectiveness (Phase 2)Study completedNCT00914615
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3)

Who this might be right for
Liver Metastasis
University Health Network, Toronto 35
Early research (Phase 1)Ended earlyNCT05375604
What this trial is testing

ExoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From EIther Primary Gastric Cancer or Colorectal Cancer (CRC)

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)Gastric Cancer Metastatic to LiverColorectal Cancer Metastatic to Liver
Codiak BioSciences 9
Not applicableStudy completedNCT06779734
What this trial is testing

Radiomics of Colorectal Liver Metastases: Identification of New Prognostic Biomarkers.

Who this might be right for
Liver Metastases From Colorectal Cancer (mCRC)
Istituto Clinico Humanitas 400
Not applicableActive Not RecruitingNCT04161092
What this trial is testing

The Swedish Study of Liver Transplantation for Non-resectable Colorectal Cancer Metastases

Who this might be right for
Colorectal CancerLiver MetastasesColorectal Liver Metastases
Vastra Gotaland Region 45
Testing effectiveness (Phase 2)Study completedNCT00056030
What this trial is testing

Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 73
Not applicableUnknownNCT02355353
What this trial is testing

Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer

Who this might be right for
Liver MetastasesColorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 31
Early research (Phase 1)Ended earlyNCT03370198
What this trial is testing

Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colon Cancer Liver Metastasis
Celyad Oncology SA 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06490913
What this trial is testing

Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes

Who this might be right for
Liver Metastases of Colorectal Cancer
Fujian Cancer Hospital 33
Not applicableUnknownNCT00299299
What this trial is testing

Modelling Internal Hepatic Movement With an External Abdominal Marker

Who this might be right for
Patients With Liver Metastases From Colorectal Cancer
Royal Marsden NHS Foundation Trust 10
Not applicableLooking for participantsNCT07001085
What this trial is testing

CtDNA Monitoring in Patients With HCC and mCRC

Who this might be right for
HCC - Hepatocellular CarcinomaColorectal Cancer Metastatic
Medical University of Warsaw 300
Testing effectiveness (Phase 2)Study completedNCT00028626
What this trial is testing

Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03803436
What this trial is testing

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

Who this might be right for
Liver MetastasesColorectal Cancer MetastaticLiver Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Testing effectiveness (Phase 2)WithdrawnNCT02345746
What this trial is testing

Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver Metastasis

Who this might be right for
Metastatic Colorectal Cancer
Western Regional Medical Center
Testing effectiveness (Phase 2)Study completedNCT00003753
What this trial is testing

Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02015754
What this trial is testing

Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal Cancer
Yale University 14
Load More Results